Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C72H86N12O20S |
| Molecular Weight | 1471.587 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCNC(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=CC(=CC=C2)[C@@H](CC(O)=O)NC(=O)NC3=CC=C(NC(=O)NCCOCCOCCOCCC(=O)N[C@@H](CC(O)=O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](C(C)C)C(=O)O[C@]5(CC)C(=O)OCC6=C5C=C7N(CC8=C(CC)C9=C(C=CC=C9)N=C78)C6=O)C=C3
InChI
InChIKey=NIZBSXQORMTMGG-MNFWRURASA-N
InChI=1S/C72H86N12O20S/c1-6-26-73-69(95)77-46-15-12-17-48(36-46)105(98,99)82-47-16-11-14-43(35-47)55(38-60(86)87)80-71(97)76-45-23-21-44(22-24-45)75-70(96)74-27-30-101-32-34-102-33-31-100-29-25-59(85)78-56(39-61(88)89)66(92)83-28-13-20-57(83)64(90)81-62(42(4)5)67(93)104-72(8-3)53-37-58-63-51(40-84(58)65(91)52(53)41-103-68(72)94)49(7-2)50-18-9-10-19-54(50)79-63/h9-12,14-19,21-24,35-37,42,55-57,62,82H,6-8,13,20,25-34,38-41H2,1-5H3,(H,78,85)(H,81,90)(H,86,87)(H,88,89)(H2,73,77,95)(H2,74,75,96)(H2,76,80,97)/t55-,56+,57+,62+,72+/m1/s1
| Molecular Formula | C72H86N12O20S |
| Molecular Weight | 1471.587 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 15:13:50 GMT 2025
by
admin
on
Wed Apr 02 15:13:50 GMT 2025
|
| Record UNII |
L3KV5NR5PG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
13284
Created by
admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
|
PRIMARY | |||
|
L3KV5NR5PG
Created by
admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
|
PRIMARY | |||
|
156903274
Created by
admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
|
PRIMARY | |||
|
300000056618
Created by
admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
|
PRIMARY | |||
|
2418533-89-6
Created by
admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
|
PRIMARY | |||
|
C213405
Created by
admin on Wed Apr 02 15:13:50 GMT 2025 , Edited by admin on Wed Apr 02 15:13:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->LIGAND |
|
||
|
TOXIN -> CONJUGATE |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
VIP236 is a small molecule drug conjugate (SMDC) consisting of an alpha v beta 3 (?V?3) integrin binder linked to an optimized camptothecin (CPT) compound (VIP126), which is released by the enzyme neutrophil elastase (NE) in the tumor microenvironment (TME)
|